Logo image of USAS

AMERICAS GOLD AND SILVER COR (USAS) Stock Fundamental Analysis

NYSEARCA:USAS - NYSE Arca - CA03062D1006 - Common Stock - Currency: USD

1.09  +0.01 (+0.93%)

After market: 1.1 +0.01 (+0.92%)

Fundamental Rating

2

Taking everything into account, USAS scores 2 out of 10 in our fundamental rating. USAS was compared to 157 industry peers in the Metals & Mining industry. Both the profitability and financial health of USAS have multiple concerns. While showing a medium growth rate, USAS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year USAS has reported negative net income.
USAS had a negative operating cash flow in the past year.
USAS had negative earnings in each of the past 5 years.
USAS had a negative operating cash flow in each of the past 5 years.
USAS Yearly Net Income VS EBIT VS OCF VS FCFUSAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -26.81%, USAS is doing worse than 84.08% of the companies in the same industry.
Looking at the Return On Equity, with a value of -89.16%, USAS is doing worse than 87.26% of the companies in the same industry.
Industry RankSector Rank
ROA -26.81%
ROE -89.16%
ROIC N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
USAS Yearly ROA, ROE, ROICUSAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

With a Gross Margin value of 19.23%, USAS perfoms like the industry average, outperforming 54.78% of the companies in the same industry.
In the last couple of years the Gross Margin of USAS has grown nicely.
USAS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
USAS Yearly Profit, Operating, Gross MarginsUSAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

1

2. Health

2.1 Basic Checks

USAS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for USAS has been increased compared to 1 year ago.
The number of shares outstanding for USAS has been increased compared to 5 years ago.
The debt/assets ratio for USAS has been reduced compared to a year ago.
USAS Yearly Shares OutstandingUSAS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
USAS Yearly Total Debt VS Total AssetsUSAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -1.03, we must say that USAS is in the distress zone and has some risk of bankruptcy.
USAS's Altman-Z score of -1.03 is on the low side compared to the rest of the industry. USAS is outperformed by 87.90% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that USAS is not too dependend on debt financing.
USAS has a Debt to Equity ratio of 0.23. This is comparable to the rest of the industry: USAS outperforms 46.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -1.03
ROIC/WACCN/A
WACC8.77%
USAS Yearly LT Debt VS Equity VS FCFUSAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

USAS has a Current Ratio of 0.52. This is a bad value and indicates that USAS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.52, USAS is not doing good in the industry: 92.36% of the companies in the same industry are doing better.
USAS has a Quick Ratio of 0.52. This is a bad value and indicates that USAS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of USAS (0.37) is worse than 91.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.37
USAS Yearly Current Assets VS Current LiabilitesUSAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.22% over the past year.
Looking at the last year, USAS shows a quite strong growth in Revenue. The Revenue has grown by 19.88% in the last year.
The Revenue has been growing by 11.40% on average over the past years. This is quite good.
EPS 1Y (TTM)22.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)19.88%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%20.82%

3.2 Future

Based on estimates for the next years, USAS will show a very strong growth in Earnings Per Share. The EPS will grow by 27.34% on average per year.
USAS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.17% yearly.
EPS Next Y80.36%
EPS Next 2Y41.42%
EPS Next 3Y27.16%
EPS Next 5Y27.34%
Revenue Next Year23.56%
Revenue Next 2Y35.98%
Revenue Next 3Y40.85%
Revenue Next 5Y31.17%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USAS Yearly Revenue VS EstimatesUSAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
USAS Yearly EPS VS EstimatesUSAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for USAS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
USAS Price Earnings VS Forward Price EarningsUSAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USAS Per share dataUSAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1 0.15

4.3 Compensation for Growth

A more expensive valuation may be justified as USAS's earnings are expected to grow with 27.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y27.16%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for USAS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAS GOLD AND SILVER COR

NYSEARCA:USAS (8/8/2025, 8:10:33 PM)

After market: 1.1 +0.01 (+0.92%)

1.09

+0.01 (+0.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-18 2025-08-18
Inst Owners28.61%
Inst Owner Change0.94%
Ins Owners24.03%
Ins Owner Change0%
Market Cap711.07M
Analysts80
Price Target1.33 (22.02%)
Short Float %1.01%
Short Ratio1.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.93%
PT rev (3m)46.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-7.68%
Revenue NY rev (3m)-7.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.82
P/FCF N/A
P/OCF N/A
P/B 12.83
P/tB 12.83
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.16
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.81%
ROE -89.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.23%
FCFM N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.7%
Cap/Sales 20.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.37
Altman-Z -1.03
F-Score5
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)88.58%
Cap/Depr(5y)98.19%
Cap/Sales(3y)20.94%
Cap/Sales(5y)26.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y80.36%
EPS Next 2Y41.42%
EPS Next 3Y27.16%
EPS Next 5Y27.34%
Revenue 1Y (TTM)19.88%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%20.82%
Revenue Next Year23.56%
Revenue Next 2Y35.98%
Revenue Next 3Y40.85%
Revenue Next 5Y31.17%
EBIT growth 1Y-0.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1732.34%
EBIT Next 3YN/A
EBIT Next 5Y146.33%
FCF growth 1Y-62.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-546.52%
OCF growth 3YN/A
OCF growth 5YN/A